Latent membrane protein 1 of Epstein-Barr virus regulates p53 phosphorylation through MAP kinases

Cancer Letters

Volumn 255, Issue 2, 2007, Pages 219-231

  Li, Lili ^a   Guo, Lili ^a   Tao, Yongguang ^a   Zhou, Shanghui ^a   Wang, Zhenlian ^a   Luo, Wei ^a   Hu, Duosha ^a   Li, Zijian ^a   Xiao, Lanbo ^a   Tang, Min ^a   Yi, Wei ^a   Tsao, Sai Wah ^b   Cao, Ya ^a  

^a Central South University   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Epstein Barr virus; Latent membrane protein 1; MAP kinases; p53; Phosphorylation

Indexed keywords

LATENT MEMBRANE PROTEIN 1; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; PROTEIN P53; SERINE; THREONINE;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; EPSTEIN BARR VIRUS; GENETIC TRANSCRIPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY;

CELL LINE, TUMOR; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; NASOPHARYNGEAL NEOPLASMS; PHOSPHORYLATION; SERINE; THREONINE; TUMOR SUPPRESSOR PROTEIN P53; VIRAL MATRIX PROTEINS;

HUMAN HERPESVIRUS 4;

EID: 34547965826     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2007.04.014     Document Type: Article

References (61)

1. Lo K.W., and Huang D.P. Genetic and epigenetic changes in nasopharyngeal carcinoma. Semin. Cancer Biol. 12 (2002) 451-462
2. Tsao S.W., Tramoutanis G., Dawson C.W., Lo A.K., and Huang D.P. The significance of LMP1 expression in nasopharyngeal carcinoma. Semin. Cancer Biol. 12 (2002) 473-487
3. Fennewald S., van Santen V., and Kieff E. Nucleotide sequence of an mRNA transcribed in latent growth-transforming virus infection indicates that it may encode a membrane protein. J. Virol. 51 (1984) 411-419
4. Eliopoulos A.G., and Young L.S. LMP1 structure and signal transduction. Semin. Cancer Biol. 11 (2001) 435-444
5. Li H.P., and Chang Y.S. Epstein-Barr virus latent membrane protein 1: structure and functions. J. Biomed. Sci. 10 (2003) 490-504
6. Huen D.S., Henderson S.A., Croom-Carter D., and Rowe M. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-κB and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene 10 (1995) 549-560
7. Devergne O., Hatzivassiliou E., Izumi K.M., Kaye K.M., Kleijnen M.F., Kief E., and Mosialos G. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-κB activation. Mol. Cell. Biol. 16 (1996) 7098-7108
8. Eliopoulos A.G., and Young L.S. Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1). Oncogene 16 (1998) 1731-1742
9. Kieser A., Kilger E., Gires O., Ueffing M., Kolch W., and Hammerschmidt W. Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N terminal kinase cascade. EMBO J. 16 (1997) 6478-6485
10. Gires O., Kohlhuber F., Kilger E., Baumann M., Kieser A., Kaiser C., Zeidler R., Scheffer B., Ueffing M., and Hammerschmidt W. Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins. EMBO J. 18 (1999) 3064-3073
11. Chen H., Hutt-Fletcher L., Cao L., and Hayward S.D. A positive autoregulatory loop of LMP1 expression and STAT activation in epithelial cells latently infected with Epstein-Barr virus. J. Virol. 77 (2003) 4139-4148
12. Sheu L.F., Chen A., Lee H.S., Hsu H.Y., and Yu D.S. Cooperative interactions among p53, bcl-2 and Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma cells. Pathol. Int. 54 (2004) 475-485
13. Fries K.L., Miller W.E., and Raab-Traub N. Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene. J. Virol. 70 (1996) 8653-8659
14. Fries K.L., Miller W.E., and Raab-Traub N. The A20 protein interacts with the Epstein-Barr virus latent membrane protein 1 (LMP1) and alters the LMP1/TRAF1/TRADD complex. Virology 264 (1999) 159-166
15. Ai M.D., Li L.L., Zhao X.R., Wu Y., Gong J.P., and Cao Y. Regulation of survivin and CDK4 by Epstein-Barr virus encoded latent membrane protein 1 in nasopharyngeal carcinoma cell lines. Cell Res. 15 (2005) 777-784
16. Faqing T., Zhi H., Liqun Y., Min T., Huanhua G., Xiyun D., and Ya C. Epstein-Barr virus LMP1 initiates cell proliferation and apoptosis inhibition via regulating expression of survivin in nasopharyngeal carcinoma. Exp. Oncol. 27 (2005) 96-101
17. Yoshizaki T., Sato H., Furukawa M., and Pagano J.S. The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1. Proc. Natl. Acad. Sci. USA 95 (1998) 3621-3626
18. Horikawa T., Yoshizaki T., Sheen T.S., Lee S.Y., and Furukawa M. Association of latent membrane protein 1 and matrix metalloproteinase 9 with metastasis in nasopharyngeal carcinoma. Cancer 89 (2000) 715-723
19. Murono S., Inoue H., Tanabe T., Joab I., Yoshizaki T., Furukawa M., and Pagano J.S. Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells. Proc. Natl. Acad. Sci. USA 98 (2001) 6905-6910
20. Dawson C.W., Tramountanis G., Eliopoulos A.G., and Young L.S. Epstein-Barr Virus latent membrane protein 1 (LMP1) activates the phosphatidylinositol 3-kinase/Akt pathway to promote cell survival and induce actin filament remodeling. J. Biol. Chem. 278 (2003) 3694-3704
21. Roberts M.L., and Cooper N.R. Activation of a ras-MAPK-dependent pathway by Epstein-Barr virus latent membrane protein 1 is essential for cellular transformation. Virology 240 (1998) 93-99
22. Eliopoulos A.G., Gallagher N.J., Blake S.M., Dawson C.W., and Young L.S. Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production. J. Biol. Chem. 274 (1999) 16085-16096
23. Jimenez G.S., Khan S.H., Stommel J.M., and Wahl G.M. p53 regulation by post-translational modification and nuclear retention in response to diverse stresses. Oncogene 18 (1999) 7656-7665
24. Ljungman M. Dial 9-1-1 for p53: mechanisms of p53 activation by cellular stress. Neoplasia 2 (2000) 208-225
25. Bode A.M., and Dong Z. Post-translational modification of p53 in tumorigenesis. Nat. Rev. Cancer 4 (2004) 793-805
26. Effert P., McCoy R., Abdel-Hamid M., Flynn K., Zhang Q., Busson P., Tursz T., Liu E., and Raab-Traub N. Alterations of the p53 gene in nasopharyngeal carcinoma. J. Virol. 66 (1992) 3768-3775
27. Sun Y., Hegamyer G., Cheng Y.J., Hildesheim A., Chen J.Y., Chen I.H., Cao Y., Yao K.T., and Colburn N.H. An infrequent point mutation of the p53 gene in human nasopharyngeal carcinoma. Proc. Natl. Acad. Sci. USA 89 (1992) 6516-6520
28. Spruck III C.H., Tsai Y.C., Huang D.P., Yang A.S., Rideout III W.M., Gonzalez-Zulueta M., Choi P., Lo K.W., Yu M.C., and Jones P.A. Absence of p53 gene mutations in primary nasopharyngeal carcinomas. Cancer Res. 52 (1992) 4787-4790
29. Niedobitek G., Agathanggelou A., Barber P., Smallman L.A., Jones E.L., and Young L.S. P53 overexpression and Epstein-Barr virus infection in undifferentiated and squamous cell nasopharyngeal carcinomas. J. Pathol. 170 (1993) 457-461
30. Cheung F.M., Pang S.W., Yau T.K., Chow S.K., and Lo K.W. Nasopharyngeal intraepithelial lesion: latent Epstein-Barr virus infection with malignant potential. Histopathology 45 (2004) 171-179
31. Sheu L.F., Chen A., Tseng H.H., Leu F.J., Lin J.K., Ho K.C., and Meng C.L. Assessment of p53 expression in nasopharyngeal carcinoma. Hum. Pathol. 26 (1995) 380-386
32. Murono S., Yoshizaki T., Park C.S., and Furukawa M. Association of Epstein-Barr virus infection with p53 protein accumulation but not bcl-2 protein in nasopharyngeal carcinoma. Histopathology 34 (1999) 432-438
33. Chow L.W., Khoo U.S., Yuen A.P., and Wei W.I. Expression of p53 in recurrent nodal metastasis from nasopharyngeal carcinoma (NPC). Eur. J. Surg. Oncol. 23 (1997) 415-418
34. Shao J.Y., Ernberg I., Biberfeld P., Heiden T., Zeng Y.X., and Hu L.F. Epstein-Barr virus LMP1 status in relation to apoptosis, p53 expression and leucocyte infiltration in nasopharyngeal carcinoma. Anticancer Res. 24 (2004) 2309-2318
35. Fan S.Q., Ma J., Zhou J., Xiong W., Xiao B.Y., Zhang W.L., Tan C., Li X.L., Shen S.R., Zhou M., Zhang Q.H., Ou Y.J., Zhuo H.D., Fan S., Zhou Y.H., and Li G.Y. Differential expression of Epstein-Barr virus-encoded RNA and several tumor-related genes in various types of nasopharyngeal epithelial lesions and nasopharyngeal carcinoma using tissue microarray analysis. Hum. Pathol. 37 (2006) 593-605
36. Wang L.F., Chai C.Y., and Kuo W.R. The prognostic value of proliferating cell nuclear antigen (PCNA) and p53 protein expression in patients with advanced nasopharyngeal carcinoma. Acta Otolaryngol. 126 (2006) 769-774
37. Thornburg N.J., Kulwichit W., Edwards R.H., Shair K.H., Bendt K.M., and Raab-Traub N. LMP1 signaling and activation of NF-kappaB in LMP1 transgenic mice. Oncogene 25 (2006) 288-297
38. Lo K.W., Mok C.H., Huang D.P., Liu Y.X., Choi P.H., Lee J.C., and Tsao S.W. p53 mutation in human nasopharyngeal carcinomas. Anticancer Res. 12 (1992) 1957-1963
39. Deng L., Yang J., Zhao X.R., Deng X.Y., Zeng L., Gu H.H., Tang M., and Cao Y. Cells in G2/M phase increased in human nasopharyngeal carcinoma cell line by EBV-LMP1 through activation of NF-kappaB and AP-1. Cell Res. 13 (2003) 187-194
40. Tsao S.W., Wang X., Liu Y., Cheung Y.C., Feng H., Zheng Z., Wong N., Yuen P.W., Lo A.K., Wong Y.C., and Huang D.P. Establishment of two immortalized nasopharyngeal epithelial cell lines using SV40 large T and HPV16E6/E7 viral oncogenes. Biochim. Biophys. Acta 1590 (2002) 150-158
41. Richardson C., Fielding C., Rowe M., and Brennan P. Epstein-Barr virus regulates STAT1 through latent membrane protein 1. J. Virol. 77 (2003) 4439-4443
42. Sheng Y., Saridakis V., Sarkari F., Duan S., Wu T., Arrowsmith C.H., and Frappier L. Molecular recognition of p53 and MDM2 by USP7/HAUSP. Nat. Struct. Mol. Biol. 13 (2006) 285-291
43. Saridakis V., Sheng Y., Sarkari F., Holowaty M.N., Shire K., Nguyen T., Zhang R.G., Liao J., Lee W., Edwards A.M., Arrowsmith C.H., and Frappier L. Structure of the p53 binding domain of HAUSP/USP7 bound to Epstein-Barr nuclear antigen 1 implications for EBV-mediated immortalization. Mol. Cell. 18 (2005) 25-36
44. Chen W., and Cooper N.R. Epstein-Barr virus nuclear antigen 2 and latent membrane protein independently transactivate p53 through induction of NF-kappaB activity. J. Virol. 70 (1996) 4849-4853
45. Lin C.S., Kuo H.H., Chen J.Y., Yang C.S., and Wang W.B. Epstein-barr virus nuclear antigen 2 retards cell growth, induces p21 (WAF1) expression, and modulates p53 activity post-translationally. J. Mol. Biol. 303 (2000) 7-23
46. O'Neill F.J., Hu Y., Chen T., and Carney H. Identification of p53 unbound to T-antigen in human cells transformed by simian virus 40 T-antigen. Oncogene 14 (1997) 955-965
47. Ludlow J.W. Use of sequential immunoprecipitation to reveal discrete, separable populations of SV40 T-antigen binding to host cellular proteins. J. Virol. Methods 59 (1996) 105-112
48. Kohli M., and Jorgensen T.J. The influence of SV40 immortalization of human fibroblasts on p53-dependent radiation responses. Biochem. Biophys. Res. Commun. 257 (1999) 168-176
49. Hess R.D., and Brandner G. DNA-damage-inducible p53 activity in SV40-transformed cells. Oncogene 15 (1997) 2501-2504
50. Lober C., Lenz-Stoppler C., and Dobbelstein M. Adenovirus E1-transformed cells grow despite the continuous presence of transcriptionally active p53. J. Gen. Virol. 83 (2002) 2047-2057
51. Buschmann T., Adler V., Matusevich E., Fuchs S.Y., and Ronai Z. p53 phosphorylation and association with murine double minute 2, c-Jun NH2-terminal kinase, p14ARF, and p300/CBP during the cell cycle and after exposure to ultraviolet irradiation. Cancer Res. 60 (2000) 896-900
52. Xia L., Paik A., and Li J.J. p53 activation in chronic radiation-treated breast cancer cells: regulation of MDM2/p14ARF. Cancer Res. 64 (2004) 221-228
53. Dirmeier U., Hoffmann R., Kilger E., Schultheiss U., Briseno C., Gires O., Kieser A., Eick D., Sugden B., and Hammerschmidt W. Latent membrane protein 1 of Epstein-Barr virus coordinately regulates proliferation with control of apoptosis. Oncogene 24 (2005) 1711-1717
54. Hatzivassiliou E.G., Tsichritzis T., and Mosialos G. Induction of apoptosis by rewiring the signal transduction of Epstein-Barr virus oncoprotein LMP1 toward caspase activation. J. Virol. 79 (2005) 5215-5219
55. Crook T., Nicholls J.M., Brooks L., O'Nions J., and Allday M.J. High level expression of deltaN-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)?. Oncogene 19 (2000) 3439-3444
56. Chu W.K., Lee K.C., Chow S.E., and Chen J.K. Dual regulation of the DeltaNp63 transcriptional activity by DeltaNp63 in human nasopharyngeal carcinoma cell. Biochem. Biophys. Res. Commun. 342 (2006) 1356-1360
57. Chen W., Huang S., and Cooper N.R. Levels of p53 in Epstein-Barr virus-infected cells determine cell fate: apoptosis, cell cycle arrest at the G1/S boundary without apoptosis, cell cycle arrest at the G2/M boundary without apoptosis, or unrestricted proliferation. Virology 251 (1998) 217-226
58. Floettmann J.E., Ward K., Rickinson A.B., and Rowe M. Cytostatic effect of Epstein-Barr virus latent membrane protein-1 analyzed using tetracycline-regulated expression in B cell lines. Virology 223 (1996) 29-40
59. Allday M.J., Sinclair A., Parker G., Crawford D.H., and Farrell P.J. Epstein-Barr virus efficiently immortalizes human B cells without neutralizing the function of p53. EMBO J. 14 (1995) 1382-1391
60. Le Clorennec C., Youlyouz-Marfak I., Adriaenssens E., Coll J., Bornkamm G.W., and Feuillard J. EBV latency III immortalization program sensitizes B cells to induction of CD95-mediated apoptosis via LMP1: role of NF-kappaB, STAT1, and p53. Blood 107 (2006) 2070-2078
61. Zhang Q., Gutsch D., and Kenney S. Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency. Mol. Cell. Biol. 14 (1994) 1929-1938